Globus Medical CEO Daniel Scavilla has resigned to take over the corner office at Dentsply Sirona, the companies announced ...

Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s full-year revenue guidance of $2.85 ...

Globus Medical will announce Q1 2025 financial results on May 8, followed by a teleconference. Quiver AI Summary Globus Medical, Inc. announced that it will release its financial results for the ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out why GMED stock is a Hold.

Analysts have recently evaluated Globus Medical and provided 12-month price targets. The average target is $73.25, accompanied by a high estimate of $80.00 and a low estimate of $68.00. A 14.58% ...